Oncodia empowers healthcare providers with regulatory compliant software to more accurately find the tumor mutations controlling treatment decisions and therefore helps to control the rapidly increasing treatment expenses for new targeted cancer drugs and checkpoint inhibitors.
Oncodia Headquarter Location
Uppsala, 751 83,
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections containing Oncodia
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Oncodia is included in 3 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Companies that use or incorporate digital technology into their health/wellness product & service offerings. Only those that have raised funding after 01/01/2010